Cargando…
Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
Cervical cancer is one of the most common malignancies among females. As a virus-related cancer, cervical cancer has attracted a lot of attention to develop virus-targeted immune therapy, including vaccine and adoptive immune cell therapy (ACT). Adoptive tumor infiltrating lymphocytes (TILs) cell th...
Autores principales: | Zhu, Yahui, Zhou, Jing, Zhu, Lijing, Hu, Wenjing, Liu, Baorui, Xie, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897649/ https://www.ncbi.nlm.nih.gov/pubmed/35468048 http://dx.doi.org/10.1080/21645515.2022.2060019 |
Ejemplares similares
-
Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
por: Gong, Xiaoling, et al.
Publicado: (2022) -
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
por: Nagata, Yusuke, et al.
Publicado: (2022) -
The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
por: Ling, Qiaoyun, et al.
Publicado: (2022) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022)